The Relationship Between Serum Cytokine Levels and the Degree of Psychosis and Cognitive Impairment in Patients With Methamphetamine-Associated Psychosis in Chinese Patients
- PMID: 33362607
- PMCID: PMC7759545
- DOI: 10.3389/fpsyt.2020.594766
The Relationship Between Serum Cytokine Levels and the Degree of Psychosis and Cognitive Impairment in Patients With Methamphetamine-Associated Psychosis in Chinese Patients
Abstract
Background: Cytokine levels can be changed in methamphetamine (METH) use disorders (MUDs) and primary psychosis. The present study assessed serum levels of some kinds of interleukins (ILs) in METH-associated psychosis (MAP) and their relationships with psychotic symptoms and cognitive dysfunction. Methods: Serum IL-2R, IL-6, IL-8, and IL-10 levels were examined by chemiluminescence assays in MAP patients (n = 119) and healthy controls (n = 108). The Positive and Negative Syndrome Scale (PANSS) and Montreal Cognitive Assessment (MOCA) were administered. Results: Serum levels of IL-6 and IL-8 were significantly increased in MAP patients (all p < 0.05). There was a negative relationship between IL-2R levels and PANSS positive (P) subscale scores (r = -0.193, p = 0.035). IL-6, IL-8 and IL-10 levels were all negatively correlated with the naming, delayed recall and orientation subscores on the MOCA (r = -0.209, p = 0.022; r = -0.245, p = 0.007; r = -0.505, p < 0.001, respectively). Conclusions: Our results indicate that immune disturbances are related to MAP and that IL-2R, IL-6, IL-8, and IL-10 are associated with the severity of psychotic symptoms and cognitive function impairment.
Keywords: addiction; cognitive; methamphetamine; psychosis; serum cytokine.
Copyright © 2020 Yang, Zhao, Liu, Xie, Zhou, Deng and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.Drug Alcohol Depend. 2015 Mar 1;148:158-64. doi: 10.1016/j.drugalcdep.2014.12.035. Epub 2015 Jan 13. Drug Alcohol Depend. 2015. PMID: 25601645
-
The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia.Psychiatry Res. 2018 Oct;268:467-472. doi: 10.1016/j.psychres.2018.07.041. Epub 2018 Jul 31. Psychiatry Res. 2018. PMID: 30138859
-
Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand.Drug Alcohol Depend. 2020 May 1;210:107961. doi: 10.1016/j.drugalcdep.2020.107961. Epub 2020 Mar 19. Drug Alcohol Depend. 2020. PMID: 32302795
-
A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology.Front Psychiatry. 2018 Oct 10;9:491. doi: 10.3389/fpsyt.2018.00491. eCollection 2018. Front Psychiatry. 2018. PMID: 30364176 Free PMC article. Review.
-
Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options.Hum Psychopharmacol. 2019 Sep;34(5):e2710. doi: 10.1002/hup.2710. Epub 2019 Aug 22. Hum Psychopharmacol. 2019. PMID: 31441135 Review.
Cited by
-
Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine.Front Psychiatry. 2023 Nov 9;14:1259041. doi: 10.3389/fpsyt.2023.1259041. eCollection 2023. Front Psychiatry. 2023. PMID: 38025429 Free PMC article.
-
Characterization of serum and brain cytokine levels following prolonged binge-like methamphetamine self-administration and cued methamphetamine seeking.J Neuroimmunol. 2025 Mar 15;400:578530. doi: 10.1016/j.jneuroim.2025.578530. Epub 2025 Jan 17. J Neuroimmunol. 2025. PMID: 39854936
-
Interactive effect of BDNF rs10835210 polymorphism and childhood maltreatment on cognitive functioning in Chinese male patients with methamphetamine use disorder.Eur Arch Psychiatry Clin Neurosci. 2025 Jun 28. doi: 10.1007/s00406-025-02038-4. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 40580351
-
Exercise modulates central and peripheral inflammatory responses and ameliorates methamphetamine-induced anxiety-like symptoms in mice.Front Mol Neurosci. 2022 Aug 29;15:955799. doi: 10.3389/fnmol.2022.955799. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36106141 Free PMC article.
-
Cognitive impairment and changes of red blood cell components and serum levels of IL-6, IL-18, and L-tryptophan in methamphetamine abusers.Am J Neurodegener Dis. 2023 Feb 25;12(1):1-15. eCollection 2023. Am J Neurodegener Dis. 2023. PMID: 36937109 Free PMC article.
References
-
- UNODC World Drug Report. Vienna, NY: United Nations Office of Drugs on Crime; (2018).
-
- Chinese National Narcotics Control Commission Annual Report on Drug Control in China. Zurich: (2018).
LinkOut - more resources
Full Text Sources